about
"Man-in-the-barrel" syndrome as delayed manifestation of extrapontine and central pontine myelinolysis: beneficial effect of intravenous immunoglobulin.Irreversible papillitis and ophthalmoparesis as a presenting manifestation of neurobrucellosis.Stroke in Qatar: a one-year, hospital-based study.Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from Qatar.Burden of Stroke in Qatar.Epilepsy in Qatar: Causes, treatment, and outcome.Slow pseudoperiodic lateralized epileptiform discharges in nonconvulsive status epilepticus in a patient with cerebral palsy and a large central meningioma.Sustained-release valproate in partial epilepsy: comparison between VIPe and Gulf VIPe study findings.Clinical presentation, epidemiology, neurophysiological findings, treatment and outcome of nonconvulsive status epilepticus: a 3-year prospective, hospital-based study.Neurocysticercosis presenting as a vertical one-and-a-half syndrome with associated contralesional horizontal gaze paresis.Ischaemic posterior circulation stroke in State of Qatar.Clinical Reasoning: A young man with acute encephalopathy, loss of vision, and upper motor neuron signs.Vertical one-and-a-half syndrome with contralesional pseudo-abducens palsy in a patient with thalamomesencephalic stroke.Oral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overview.Cyclosporin neurotoxicity presenting as an unilateral foot drop in a renal transplant patient[New functional exploration of the nervous system: evoked potentials and their clinical interest]Hemifacial spasm resulting from vertebral artery dolichoectasiaAdult opsoclonus-myoclonus syndrome following Mycoplasma pneumoniae infection with dramatic response to plasmapheresisCharacteristics of patients with confirmed epilepsy and psychogenic nonepileptic seizures in QatarNovel therapies for epilepsy in the pipelineElectroencephalography in epilepsy: look for what could be beyond the visual inspection
P50
Q30992772-BA6F39C2-FF90-4AFF-B335-FC8696EA94EDQ36744272-81611351-F9D2-4CC4-8787-4F274FCE9FFEQ36954945-2F35A905-54C8-47C5-912A-DA5293710385Q39021942-2D200F99-299F-4F93-B3E2-50A26E64BE1FQ40278325-F5F80823-DA45-4AE0-BF30-16F65A8066C7Q40553900-DFD84608-D78D-417C-A995-F2C63F0347E1Q42086606-04F51DF4-9281-40F7-BEB7-01AB48EE5303Q46442740-8837032F-2D10-428B-9791-667192805764Q47108940-40AED2F0-086D-48EB-9DC3-84036B2FD897Q48375920-19B0DAAD-0CA3-483C-B547-A26CD9DA5C3BQ48564027-A6F135C8-E97F-40B7-BFCD-C2B85B721166Q48748255-0889E567-6B35-481A-9CD1-C318AF974E16Q48900037-96F1A92C-479F-4E77-9511-DF91E8309850Q53681845-42E9E835-1BB9-4D17-B4E0-35B7D91F4813Q67922476-F7EDE24A-BCE2-48D4-9C68-201A05C365C0Q70708228-C893576C-0E10-4FD0-8F04-C0CDA791DCE7Q81357727-BBED89BA-2C20-43E7-9E32-476722057DFFQ84544489-4D44BC5E-646F-471C-8223-406F90B82FFEQ89448362-48DEDE60-6B2F-4492-A627-C7E25976B07AQ91712383-D367B71F-2EB4-4171-97EC-791B09AF5E57Q92216404-25FD4BBA-A655-4BF5-B536-6596186CE169
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
B Mesraoua
@ast
B Mesraoua
@es
Boulenouar Mesraoua
@en
Boulenouar Mesraoua
@nl
Boulenouar Mesraoua
@pl
type
label
B Mesraoua
@ast
B Mesraoua
@es
Boulenouar Mesraoua
@en
Boulenouar Mesraoua
@nl
Boulenouar Mesraoua
@pl
altLabel
B Mesraoua
@en
prefLabel
B Mesraoua
@ast
B Mesraoua
@es
Boulenouar Mesraoua
@en
Boulenouar Mesraoua
@nl
Boulenouar Mesraoua
@pl
P31
P496
0000-0001-8625-7365